Jun 20 |
Precision BioSciences Expands Hepatitis Scientific Advisory Board with Addition of World-Class Clinical Investigators Mark Sulkowski, M.D. and Jordan Feld, M.D., MPH, as PBGENE-HBV Program Nears Clinical Readiness
|
Jun 5 |
Precision BioSciences Presents New Preclinical Safety Data for PBGENE-HBV Clinical Candidate at the European Association for the Study of the Liver Congress
|
May 30 |
Precision BioSciences to Participate in Upcoming June Investor Conferences
|
May 29 |
Does Precision BioSciences (DTIL) Have the Potential to Rally 200.55% as Wall Street Analysts Expect?
|
May 17 |
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
|
May 16 |
Deep Dive Into Precision BioSciences Stock: Analyst Perspectives (4 Ratings)
|
May 13 |
Precision BioSciences GAAP EPS of $1.70, revenue of $17.58M beats by $11.56M
|
May 13 |
Precision BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
|
May 10 |
Precision BioSciences Q1 Earnings Preview
|
May 8 |
Precision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private Placement
|